We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Merck’s vaccines powered ahead to start the year, helping the drug giant offset other areas of weakness on the way to slight growth overall. Led by HPV vaccine franchise Gardasil and pneumococcal shot Pneumovax 23, Merck’s vaccine sales grew 21% in the fi